JOSE BARAHONA: Open Payments
NPI 1720151509 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,446 in 149 payments from 24 companies in 2025. Trend: 2023 $1,881 · 2024 $2,910 · 2025 $3,446
Food & beverage: $2,946Speaker / faculty: $500
| Company | Payments | Amount |
|---|---|---|
| QIAGEN, LLC | 1 | $500 |
| ABBVIE INC. | 17 | $351 |
| Ardelyx, Inc. | 11 | $292 |
| AstraZeneca Pharmaceuticals LP | 9 | $284 |
| Corcept Therapeutics | 12 | $276 |
| Merck Sharp & Dohme LLC | 17 | $239 |
| Novo Nordisk Inc | 7 | $236 |
| Lundbeck LLC | 13 | $227 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $218 |
| Amgen Inc. | 12 | $188 |
Products named: IBSRELA, Korlym, VRAYLAR, REXULTI, Kerendia, VERQUVO, Ozempic, XIFAXAN.
Industry payments across TX — which companies pay providers there.
